Know Labs, INC S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
USBC, Inc. has filed Amendment No. 4 to its Form S-1 Registration Statement, updating disclosures and adding exhibits related to its tokenized deposit offering and Bitcoin treasury strategy.
USBC, Inc. has filed an amendment to its S-1 registration statement, reducing the number of shares of common stock offered by selling stockholders and incorporating recent financial reports.
USBC, Inc. has filed an amendment to its registration statement to facilitate the resale of 367.6 million shares of common stock by existing stockholders.
USBC, Inc. files an amended S-1 registration statement for the resale of 367.6 million common shares by selling stockholders, including Goldeneye 1995 LLC, without receiving any proceeds.
USBC, Inc. files an S-1 registration statement to allow selling stockholders to resell 367.6 million common shares, following a major strategic pivot into digital assets and banking, including a Bitcoin treasury.
Know Labs is seeking to raise approximately $4.0 million through a public offering of units, each consisting of one share of common stock and one warrant, to further develop its non-invasive glucose monitoring technology.
Know Labs files an amendment to its S-1 registration statement, primarily to include the consent of its independent registered public accounting firm.
Know Labs files an amendment to its S-1 registration statement for a unit offering consisting of common stock and warrants, aiming to raise capital for ongoing operations.
S-1/A: Know Labs Eyes $6 Million in Public Offering to Advance Non-Invasive Glucose Monitoring Technology
Know Labs aims to raise $6 million through a public offering of units to further develop and commercialize its non-invasive glucose monitoring technology.
Know Labs, Inc. plans to raise approximately $6.5 million through a unit offering to further develop and commercialize its non-invasive medical diagnostic technology.
Know Labs files for a firm commitment public offering of units consisting of common stock and warrants to fund the development and commercialization of its non-invasive glucose monitoring technology.
Know Labs has filed an amendment to its Form S-1 registration statement to allow a selling stockholder to resell up to 10,800,000 shares of common stock.
Know Labs has filed a registration statement for the potential resale of up to 10.8 million shares of its common stock by a selling stockholder.